Record Information |
---|
Version | 2.0 |
---|
Created at | 2021-01-06 06:58:09 UTC |
---|
Updated at | 2021-07-15 17:37:02 UTC |
---|
NP-MRD ID | NP0021695 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Toyocamycin |
---|
Provided By | NPAtlas |
---|
Description | Toyocamycin is also known as a-399-y4 or ahygroscopin-b. Toyocamycin is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Toyocamycin is found in Streptomyces diastatochromogenes, Streptomyces toyocaensis and Tolypothrix tenuis. Toyocamycin was first documented in 1968 (PMID: 5634627). Based on a literature review a small amount of articles have been published on toyocamycin (PMID: 22629386) (PMID: 22852048) (PMID: 23775805) (PMID: 23900861). |
---|
Structure | [H]OC([H])([H])[C@@]1([H])O[C@@]([H])(N2C([H])=C(C#N)C3=C(N=C([H])N=C23)N([H])[H])[C@]([H])(O[H])[C@]1([H])O[H] InChI=1S/C12H13N5O4/c13-1-5-2-17(11-7(5)10(14)15-4-16-11)12-9(20)8(19)6(3-18)21-12/h2,4,6,8-9,12,18-20H,3H2,(H2,14,15,16)/t6-,8-,9-,12-/m1/s1 |
---|
Synonyms | Value | Source |
---|
4-Amino-5-cyano-7-(D-ribofuranosyl)-7H-pyrrolo(2,3-D)pyrimidine | ChEBI | 7-Deaza-7-cyanoadenosine | ChEBI | a-399-Y4 | ChEBI | Ahygroscopin-b | ChEBI | Antibiotic 1037 | ChEBI | Antibiotic a-399-y4 | ChEBI | Antibiotic e212 | ChEBI | Cyanotubericidin | ChEBI | e-212 | ChEBI | Siromycin | ChEBI | Uramycin b | ChEBI | Vengicide | ChEBI | UNAMYCIN b | ChEMBL | Toyokamycin | MeSH | Deazacyanoadenosine | MeSH |
|
---|
Chemical Formula | C12H13N5O4 |
---|
Average Mass | 291.2627 Da |
---|
Monoisotopic Mass | 291.09675 Da |
---|
IUPAC Name | 4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile |
---|
Traditional Name | 4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile |
---|
CAS Registry Number | Not Available |
---|
SMILES | NC1=NC=NC2=C1C(=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C#N |
---|
InChI Identifier | InChI=1S/C12H13N5O4/c13-1-5-2-17(11-7(5)10(14)15-4-16-11)12-9(20)8(19)6(3-18)21-12/h2,4,6,8-9,12,18-20H,3H2,(H2,14,15,16)/t6-,8-,9-,12-/m1/s1 |
---|
InChI Key | XOKJUSAYZUAMGJ-WOUKDFQISA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as pyrrolopyrimidine nucleosides and nucleotides. These are nucleoside derivatives containing a ribose derivative which is n-glycosylated to a pyrrolopyrimidine. Also called deazapurine nucleosides, they are analogs of purine nucleosides with the N atom of the purine being replaced by a C atom at position 7. |
---|
Kingdom | Organic compounds |
---|
Super Class | Nucleosides, nucleotides, and analogues |
---|
Class | Pyrrolopyrimidine nucleosides and nucleotides |
---|
Sub Class | Not Available |
---|
Direct Parent | Pyrrolopyrimidine nucleosides and nucleotides |
---|
Alternative Parents | |
---|
Substituents | - Pyrrolopyrimidine ribonucleoside
- Glycosyl compound
- N-glycosyl compound
- Pentose monosaccharide
- Pyrrolo[2,3-d]pyrimidine
- Pyrrolopyrimidine
- Aminopyrimidine
- Monosaccharide
- Pyrimidine
- Imidolactam
- Substituted pyrrole
- Heteroaromatic compound
- Pyrrole
- Tetrahydrofuran
- Secondary alcohol
- Carbonitrile
- Nitrile
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organooxygen compound
- Organonitrogen compound
- Amine
- Alcohol
- Hydrocarbon derivative
- Organopnictogen compound
- Organic nitrogen compound
- Primary alcohol
- Primary amine
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Tolman RL, Robins RK, Townsend LB: Pyrrolo[2,3-d]pyrimidine nucleoside antibiotics. Total synthesis and structure of toyocamycin, unamycin B, vengicide, antibiotic E-212, and Sangivamycin (BA-90912). J Am Chem Soc. 1968 Jan 17;90(2):524-6. doi: 10.1021/ja01004a076. [PubMed:5634627 ]
- Kiburu IN, LaRonde-LeBlanc N: Interaction of Rio1 kinase with toyocamycin reveals a conformational switch that controls oligomeric state and catalytic activity. PLoS One. 2012;7(5):e37371. doi: 10.1371/journal.pone.0037371. Epub 2012 May 22. [PubMed:22629386 ]
- Ri M, Tashiro E, Oikawa D, Shinjo S, Tokuda M, Yokouchi Y, Narita T, Masaki A, Ito A, Ding J, Kusumoto S, Ishida T, Komatsu H, Shiotsu Y, Ueda R, Iwawaki T, Imoto M, Iida S: Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing. Blood Cancer J. 2012 Jul;2(7):e79. doi: 10.1038/bcj.2012.26. Epub 2012 Jul 20. [PubMed:22852048 ]
- Ma Z, Liu J, Shentu X, Bian Y, Yu X: Optimization of electroporation conditions for toyocamycin producer Streptomyces diastatochromogenes 1628. J Basic Microbiol. 2014 Apr;54(4):278-84. doi: 10.1002/jobm.201200489. Epub 2013 Jun 17. [PubMed:23775805 ]
- Ma Z, Liu J, Lin X, Shentu X, Bian Y, Yu X: Formation, regeneration, and transformation of protoplasts of Streptomyces diastatochromogenes 1628. Folia Microbiol (Praha). 2014 Mar;59(2):93-7. doi: 10.1007/s12223-013-0271-5. Epub 2013 Jul 31. [PubMed:23900861 ]
|
---|